abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
No Form 4 insider filings for HQL were recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0000884121 (2026-04-11) ↗